Smoking is a risk factor for many diseases and kills more than 8 million people globally every year. It is well established that any kind of smoking is harmful and seriously affects the cardiovascular and respiratory systems. COVID-19 can harm cardiovascular and respiratory systems while the damage caused to the lungs by smoking makes patients more susceptible to pulmonary infections, both bacterial and viral.
A systematic review of the most recent epidemiological data from the studies already published in China, concluded that smokers suffer more severely from COVID-19, being 2.4 times more likely to be admitted to an ICU, need mechanical ventilation or die compared to non-smokers (95% CI: 1.43–4.04); it seems that their probability of having severe symptoms is also increased (Δ: 40%).
In this new fact sheet, ENSP summarized evidence for smokers and novel tobacco users and made recommendations to be followed in the context of COVID-19 pandemic.
Read the full fact sheet (EN)…
Read the full fact sheet (FR)…
Read the full fact sheet (RO)…
Read the full fact sheet (AL)…
We are excited to announce the release of the 4th Edition of the ENSP Tobacco and Nicotine Dependence Treatment Guidelines! This updated version includes important enhancements to keep you...
Tobacco consumption remains a leading cause of preventable death and disease in the EU, linked to cancer, cardiovascular, and respiratory conditions, with second-hand smoke and novel products posing additional...
On November 12th 2024, the Social Protection, Health and Family Commission in Moldova’s Parliament held a crucial debate on the draft Law no. 280, focusing on strengthening tobacco control...
